EXHIBIT 99.1

ATHEROGENICS, INC.

(Debtor-in-Possession)

BALANCE SHEET

February 28, 2009

(Unaudited)

Assets
Current assets:
Cash and cash equivalents	$    47,785,469
Prepaid expenses	328,945
Interest receivable and other current assets	17,579
Total current assets	48,131,993
Equipment and leasehold improvements, net of accumulated depreciation
and amortization	703,116
Total assets	$    48,835,109
Liabilities and Shareholders' Deficit
Current liabilities:
Accounts payable	$          50,894
Accrued compensation	158,192
Accrued and other liabilities	165,150
Total current liabilities not subject to compromise	374,236
Prepetition liabilities	306,680,232
Shareholders' deficit
Common stock	218,861,985
Warrants	598,172
Accumulated deficit	(477,679,516	)
Total shareholders' deficit	(258,219,359	)
Total liabilities and shareholders' deficit	$    48,835,109

ATHEROGENICS, INC.

(Debtor-in-Possession)

STATEMENT OF OPERATIONS

For the month ended February 28, 2009

(Unaudited)

Revenues	$                    —
Operating expenses (1):
Research and development	687,182
General and administrative	424,514
Total operating expenses	1,111,696
Operating loss	(1,111,696	)
Interest and other income	—
Interest expense	—
Net loss before reorganization items	(1,111,696	)
Reorganization items, net	(121,581	)
Net loss	$      (1,233,277	)
Net loss per share –
basic and diluted	$               (0.03	)
Weighted average shares
outstanding – basic and diluted	39,518,492

(1) Operating expenses include non-cash depreciation expense of $195,171.